The van de Rijn & West Lab In The Department of Pathology
noThumbs = false, sDelay = 8000, sIndexType = symbols

Research in the van de Rijn & West lab

Translocation of CSF1 in PVNS by FISH

Research in the van de Rijn & West lab

DTF and SFT gene signatures in breast cancer

Research in the van de Rijn & West lab

DOG1: A new diagnostic marker

Research in the van de Rijn & West lab

3SEQ from Archival Tumor Samples

Research in the van de Rijn & West lab

Endogenous versus tumor-specific host response to breast carcinoma

Research in the van de Rijn & West lab

Antibody Therapy Targeting CD47 protein in LMS

Research in the van de Rijn & West lab

ROR2 is a novel prognostic biomarker

The van de Rijn & West lab

Matt van de Rijn, M.D.Ph.D. Dr. West
Matt van de Rijn, M.D.Ph.D.
Professor,
Department of Pathology
Room L225
Stanford University Medical Center
300 Pasteur Dr.
Stanford, CA94305
Phone: (650) 498-7154
Fax: (650) 725-6902
C.V. | mrijn@stanford.edu

Rob West, MD, PhD
Associate Professor
Department of Pathology
Room L229A
Stanford University Medical Center
300 Pasteur Drive
Stanford, CA 94305
Phone: (650) 736-2664
Fax: (650) 725-6902
Email: rbwest@stanford.edu

Our research focuses on the study of human soft tissue tumors and carcinomas using ultra high-throughput sequencing, genomics, gene microarray, and tissue microarray technology. We perform global gene expression analysis followed by validation of the data with in situ hybridization or immunohistochemistry on tissue microarrays. Our goal is to find new diagnostic and prognostic markers in sarcoma and cancer, and to identify potential therapeutic targets.

 

gene microarray
tissue microarray

Click to see our current publications

Molecular characterisation of soft tissue tumours: a gene expression study.Gene Expression Patterns and Gene Copy Number Changes in Dermatofibrosarcoma Protuberans Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarraysGene expression in the normal adult human kidney assessed by complementary DNA microarray.High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomasThe novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation statusApo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberansGastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profilesDetermination of Stromal Signatures in Breast Carcinoma The gene expression profile of extraskeletal myxoidA landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells


Stanford Medicine Resources:

Footer Links: